PA
APLS

Perceptive Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Perceptive Advisors’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80,956
Closed -$3.26M – 110
2026
Q1 		$3.26M Buy
+80,956
New +$1.74M 0.06% 81
2023
Q3 		– Sell
-812,037
Closed -$35.7M – 98
2023
Q2 		$74M Buy
812,037
+256,693
+46% +$22.1M 2.14% 14
2023
Q1 		$36.6M Buy
+555,344
New +$32M 1.08% 28
2022
Q4 		– Sell
-366,400
Closed -$25M – 98
2022
Q3 		$25M Buy
366,400
+45,100
+14% +$2.67M 0.73% 38
2022
Q2 		$14.5M Sell
321,300
-1,160,400
-78% -$52.9M 0.46% 50
2022
Q1 		$75.3M Buy
1,481,700
+30,000
+2% +$1.32M 1.51% 18
2021
Q4 		$68.6M Buy
1,451,700
+836,700
+136% +$32.9M 1.06% 25
2021
Q3 		$20.3M Sell
615,000
-46,162
-7% -$2.59M 0.29% 68
2021
Q2 		$41.8M Buy
+661,162
New +$34.1M 0.54% 47
2020
Q3 		– Sell
-11,418
Closed -$373K – 130
2020
Q2 		$373K Hold
11,418
– – 0.01% 123
2020
Q1 		$327K Buy
+11,418
New +$405K 0.01% 106

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Perceptive Advisors's APLS Position: Q2 2026 in Review

Perceptive Advisors sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 80,956 shares — an estimated $3.26M sold.

Perceptive Advisors first reported a position in APLS in Q1 2020 and held it in 11 quarters. The position peaked at $75.3M in Q1 2022. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Perceptive Advisors reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Perceptive Advisors sold 80,956 Apellis Pharmaceuticals shares in Q2 2026, an estimated $3.26M.
  • Perceptive Advisors first reported a position in Apellis Pharmaceuticals in Q1 2020 and held it in 11 quarters.
  • Perceptive Advisors's Apellis Pharmaceuticals position peaked at $75.3M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.